Publicacions en col·laboració amb investigadors/es de Hospital Clínico San Carlos de Madrid (36)

2017

  1. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

    Leukemia and Lymphoma, Vol. 58, Núm. 1, pp. 145-152

2014

  1. Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: Parallel study of 81 patients

    Leukemia and Lymphoma, Vol. 55, Núm. 10, pp. 2341-2348

  2. Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

    Cancer, Vol. 120, Núm. 24, pp. 3958-3964

  3. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: Final results of the PETHEMA ALL-AR-03 trial

    Journal of Clinical Oncology, Vol. 32, Núm. 15, pp. 1595-1604

2010

  1. Linezolid treatment of a prosthetic joint infection with Staphylococcus lugdunensis in a patient with multiple myeloma

    International Journal of Antimicrobial Agents

  2. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA study group

    Haematologica, Vol. 95, Núm. 4, pp. 589-596

2007

  1. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

    European Journal of Haematology, Vol. 78, Núm. 2, pp. 102-110

2005

  1. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial

    Haematologica, Vol. 90, Núm. 10, pp. 1346-1356

  2. Prevalencia y significado pronóstico de los marcadores mieloides en adultos con leucemia aguda linfoblástica de alto riesgo

    Medicina Clinica, Vol. 125, Núm. 7, pp. 241-246

2001

  1. Tratamiento de la leucemia aguda linfoblástica en adultos

    Revisiones en Cancer, Vol. 15, Núm. 6, pp. 225-230

2000

  1. Association of t(9;11)-MLL AF9 and trisomy 8 in an AML-M5 preceded by pancytopenia

    Cancer Genetics and Cytogenetics, Vol. 120, Núm. 2, pp. 144-147

1999

  1. Mieloma múltiple y otras discrasias de células plasmáticas

    Revista Clinica Espanola, Vol. 199, Núm. SUPPL. 1, pp. 52-57

  2. Relación entre la persistencia del gen BCR/ABL y la recaída en pacientes adultos con leucemia linfoblástica aguda

    Medicina Clinica, Vol. 112, Núm. 13, pp. 481-484

1998

  1. Detection of bcr/abl mRNA in a case of chronic myelogenous leukemia in long-term remission: CML or sensitivity of detection?

    Haematologica, Vol. 83, Núm. 8, pp. 744-747

  2. Late relapse in BCR/ABL-positive patients after non-intensive chemotherapy [7]

    Leukemia

1997

  1. Estudio por PCR del reordenamiento bcl-2 en el trasplante autólogo de células progenitoras de sangre periférica en el linfoma no hodgkiniano folicular

    Medicina Clinica, Vol. 108, Núm. 19, pp. 730-733

1996

  1. Autotransplantation of peripheral blood stem cells mobilized by G-CSF in hematological malignancies: Evidence for rapid and long-term sustained hematopoietic reconstitution

    Leukemia and Lymphoma, Vol. 20, Núm. 3-4, pp. 327-332

1994

  1. Characterization of a new αthalassemia-1 mutation in a Spanish family

    Hemoglobin, Vol. 18, Núm. 1, pp. 29-37

  2. Chromosomal disorder and neoplastic diseases in a family with inherited fragile 16. Causality or casualty?

    Cancer Genetics and Cytogenetics, Vol. 78, Núm. 2, pp. 160-164

1993

  1. Detecting the minimal residual disease contaminated in peripheral blood stem cell transplantation in B‐cell lymphoma

    American Journal of Hematology